Lundbeckfond Invest A/S

Insider Reports History

Location
Copenhagen, Denmark
Signature
/s/ Christian E. Elling, Managing Partner and /s/ Lene Skole, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lundbeckfond Invest A/S:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. 10%+ Owner Common Stock 1,835,959 $24,268,808 $13.22 07 Nov 2023 Direct
IO Biotech, Inc. Director, 10%+ Owner Common Stock 13,950,686 $14,438,960 $1.04 09 Aug 2023 Direct
IO Biotech, Inc. Director, 10%+ Owner Warrants (Right to Buy) 7,901,234 09 Aug 2023 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Series A convertible preferred stock 0 07 Nov 2023 Direct
Lexeo Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 07 Nov 2023 Direct

Insider Reports Filed by Lundbeckfond Invest A/S

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 07 Nov 2023 5 +$2,499,992 4 10%+ Owner 09 Nov 2023, 20:33
LXEO Lexeo Therapeutics, Inc. 02 Nov 2023 0 $0 3 10%+ Owner 02 Nov 2023, 21:37
IOBT IO Biotech, Inc. 09 Aug 2023 2 +$15,999,999 4 Director, 10%+ Owner 11 Aug 2023, 21:22
IOBT IO Biotech, Inc. 09 Nov 2021 5 +$29,999,998 4 10%+ Owner 12 Nov 2021, 15:15
IOBT IO Biotech, Inc. 04 Nov 2021 0 $0 3 10%+ Owner 04 Nov 2021, 21:32